Multi-stage HIV vaccine regimen shows promising results in Phase 1 clinical trial

Latest News

A needle withdraws the vaccine in an RSV vial.
FDA Approves Abrysvo for Adults 18-59 at Increased Risk for RSV
FDA Approves Abrysvo for Adults 18-59 at Increased Risk for RSV
mpox virus particles from NIAID Integrated Research Facility (credit: NIAID)
Mpox Vaccine Is Safe and Generates a Robust Antibody Response in Adolescents
Mpox Vaccine Is Safe and Generates a Robust Antibody Response in Adolescents
Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial
Latest news about the results of the COVAIL trial regarding the Sanofi booster. GW participated as one of the many sites for this COVID-19 vaccine study.